Dr. Kim Keppler-Noreuil, MD – Madison, WI

  • Pharmacodynamic Study of Miransertib in Individuals with Proteus Syndrome.  

    Keppler-Noreuil KM1, Sapp JC1, Lindhurst MJ1, Darling TN2, Burton-Akright J1, Bagheri M3, Dombi E4, Gruber A1, Jarosinski PF5, Martin S6, Nathan N2, Paul SM7, Savage R..., Am J Hum Genet, 3/7/2019
  • The Fourth International Symposium on Genetic Disorders of the RAS/MAPK Pathway  

    Stevenson DA, Schill L, Schoyer L, Andresen BS, Bakker A, Bayrak-Toydemir P, Burkitt-Wright E, Chatfield K, Elefteriou F, Elgersma Y, Franz D, Gelb B, Goriely A, Gripp..., American Journal of Medical Genetics, 1/1/2016
  • Twinning and major birth defects, National Birth Defects Prevention Study, 1997-2007  

    Dawson A, Tinker S, Jamieson D, Hobbs C, Berry RJ, Anderka M, Keppler-Noreuil KM, Lin AL, Reefhuis J, and the National Birth Defects Prevention Study, Journal of Epidemiology & Community Health, 1/1/2016
  • Join now to see all
  • You Might Also Like